KAT2B and breast cancer: PCAF-mediated acetylation at H3K9 at the multi drug resistance (MDR) genes was shown to contribute to the multidrug resistance of breast cancer and, knock down of PCAF significantly sensitize these cancer cells to anticancer therapeutics (66).